Clinical results of romosozumab in the treatment of osteoporosis

Clinical results of romosozumab in the treatment of osteoporosis - Clinical results of romosozumab in the treatment of osteoporosis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060325

Enrollment

500

Registered

2026-01-12

Start date

2019-03-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Severe osteoporosis

Exclusion criteria

Exclusion criteria: 1) a history of myocardial infarction or stroke 2) a history of hypersensitivity to romosozumab or its components 3) pregnancy, suspected pregnancy, or breastfeeding 4) failure to obtain written informed consent for participation in the study

Design outcomes

Primary

Measure	Time frame
Changes in lumbar and proximal femur bone mineral density, changes in bone metabolism markers, incidence of fractures, and incidence of side effects	—

Countries

Japan

Contacts

Public ContactRUI NIIMI

Niimi orthopaedics surgery clinic Orthopaedic surgery

furikakefuri@hotmail.co.jp0594332133

Outcome results